Author
Listed:
- Michael Spencer Chapman
(Wellcome Sanger Institute
Barts Cancer Institute)
- Emily Mitchell
(Wellcome Sanger Institute
Cambridge Stem Cell Institute
University of Cambridge)
- Kenichi Yoshida
(Wellcome Sanger Institute)
- Nicholas Williams
(Wellcome Sanger Institute)
- Margarete A. Fabre
(Wellcome Sanger Institute
Cambridge Stem Cell Institute
University of Cambridge
AstraZeneca)
- Anna Maria Ranzoni
(Wellcome Sanger Institute)
- Philip S. Robinson
(Wellcome Sanger Institute)
- Lori D. Kregar
(Wellcome Sanger Institute)
- Matthias Wilk
(University of Zurich and University Hospital Zurich)
- Steffen Boettcher
(University of Zurich and University Hospital Zurich)
- Krishnaa Mahbubani
(University of Cambridge
University of Cambridge)
- Kourosh Saeb Parsy
(University of Cambridge
University of Cambridge)
- Kate H. C. Gowers
(University College London)
- Sam M. Janes
(University College London)
- Stanley W. K. Ng
(Wellcome Sanger Institute)
- Matt Hoare
(University of Cambridge)
- Anthony R. Green
(Cambridge Stem Cell Institute
University of Cambridge)
- George S. Vassiliou
(Wellcome Sanger Institute
Cambridge Stem Cell Institute
University of Cambridge)
- Ana Cvejic
(Wellcome Sanger Institute
Cambridge Stem Cell Institute
University of Cambridge
University of Copenhagen)
- Markus G. Manz
(University of Zurich and University Hospital Zurich)
- Elisa Laurenti
(Cambridge Stem Cell Institute
University of Cambridge)
- Iñigo Martincorena
(Wellcome Sanger Institute)
- Michael R. Stratton
(Wellcome Sanger Institute)
- Jyoti Nangalia
(Wellcome Sanger Institute
Cambridge Stem Cell Institute
University of Cambridge)
- Tim H. H. Coorens
(Wellcome Sanger Institute
Broad Institute of MIT and Harvard)
- Peter J. Campbell
(Wellcome Sanger Institute
Cambridge Stem Cell Institute
University of Cambridge)
Abstract
DNA is subject to continual damage, leaving each cell with thousands of individual DNA lesions at any given moment1–3. The efficiency of DNA repair means that most known classes of lesion have a half-life of minutes to hours3,4, but the extent to which DNA damage can persist for longer durations remains unknown. Here, using high-resolution phylogenetic trees from 89 donors, we identified mutations arising from 818 DNA lesions that persisted across multiple cell cycles in normal human stem cells from blood, liver and bronchial epithelium5–12. Persistent DNA lesions occurred at increased rates, with distinctive mutational signatures, in donors exposed to tobacco or chemotherapy, suggesting that they can arise from exogenous mutagens. In haematopoietic stem cells, persistent DNA lesions, probably from endogenous sources, generated the characteristic mutational signature SBS1913; occurred steadily throughout life, including in utero; and endured for 2.2 years on average, with 15–25% of lesions lasting at least 3 years. We estimate that on average, a haematopoietic stem cell has approximately eight such lesions at any moment in time, half of which will generate a mutation with each cell cycle. Overall, 16% of mutations in blood cells are attributable to SBS19, and similar proportions of driver mutations in blood cancers exhibit this signature. These data indicate the existence of a family of DNA lesions that arise from endogenous and exogenous mutagens, are present in low numbers per genome, persist for months to years, and can generate a substantial fraction of the mutation burden of somatic cells.
Suggested Citation
Michael Spencer Chapman & Emily Mitchell & Kenichi Yoshida & Nicholas Williams & Margarete A. Fabre & Anna Maria Ranzoni & Philip S. Robinson & Lori D. Kregar & Matthias Wilk & Steffen Boettcher & Kri, 2025.
"Prolonged persistence of mutagenic DNA lesions in somatic cells,"
Nature, Nature, vol. 638(8051), pages 729-738, February.
Handle:
RePEc:nat:nature:v:638:y:2025:i:8051:d:10.1038_s41586-024-08423-8
DOI: 10.1038/s41586-024-08423-8
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:638:y:2025:i:8051:d:10.1038_s41586-024-08423-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.